Pharma Continues To Sit In Back Seat As Tobacco, Food Priorities Take Center Stage At FDA

 
• By Sarah Karlin-Smith
  
back seat of a car
Drug issues could get some attention as part of a broader agencywide focus on supply chain resilience, but are mostly taking a back seat to other FDA public health initiatives. • Source: Shutterstock

More from US FDA

More from Agency Leadership